Allmed Medical Products Co., Ltd (002950.SZ)
CNY 8.05
(-0.25%)
CNY 8.05
(-0.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 110.39 Million CNY | -72.86% |
| 2022 | 406.79 Million CNY | -5.66% |
| 2021 | 431.21 Million CNY | -62.75% |
| 2020 | 1.15 Billion CNY | 255.27% |
| 2019 | 325.81 Million CNY | 43.04% |
| 2018 | 227.78 Million CNY | -2.55% |
| 2017 | 233.73 Million CNY | -5.8% |
| 2016 | 248.13 Million CNY | 58.07% |
| 2015 | 156.97 Million CNY | -20.89% |
| 2014 | 198.42 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 93.11 Million CNY | -0.81% |
| 2024 Q3 | 78.16 Million CNY | -16.05% |
| 2024 Q1 | 93.87 Million CNY | 334.67% |
| 2023 Q3 | -6.63 Million CNY | -122.76% |
| 2023 Q2 | 29.15 Million CNY | -77.2% |
| 2023 Q1 | 127.88 Million CNY | -39.08% |
| 2023 FY | 110.39 Million CNY | -72.86% |
| 2023 Q4 | -40 Million CNY | -503.0% |
| 2022 Q2 | 132.38 Million CNY | -16.07% |
| 2022 FY | 406.79 Million CNY | -5.66% |
| 2022 Q4 | 209.92 Million CNY | 325.1% |
| 2022 Q3 | -93.25 Million CNY | -170.45% |
| 2022 Q1 | 157.71 Million CNY | 54.5% |
| 2021 Q2 | 121.46 Million CNY | 4.44% |
| 2021 Q1 | 116.3 Million CNY | -41.37% |
| 2021 FY | 431.21 Million CNY | -62.75% |
| 2021 Q4 | 102.08 Million CNY | 11.73% |
| 2021 Q3 | 91.36 Million CNY | -24.78% |
| 2020 FY | 1.15 Billion CNY | 255.27% |
| 2020 Q2 | 620.45 Million CNY | 580.35% |
| 2020 Q4 | 198.37 Million CNY | -19.85% |
| 2020 Q1 | 91.19 Million CNY | -15.45% |
| 2020 Q3 | 247.5 Million CNY | -60.11% |
| 2019 Q4 | 107.86 Million CNY | 1.63% |
| 2019 Q2 | 56.41 Million CNY | 1.84% |
| 2019 Q1 | 55.39 Million CNY | -36.22% |
| 2019 FY | 325.81 Million CNY | 43.04% |
| 2019 Q3 | 106.13 Million CNY | 88.12% |
| 2018 Q4 | 86.85 Million CNY | 59.42% |
| 2018 Q2 | 45.34 Million CNY | 10.33% |
| 2018 Q1 | 41.09 Million CNY | -22.98% |
| 2018 FY | 227.78 Million CNY | -2.55% |
| 2018 Q3 | 54.48 Million CNY | 20.17% |
| 2017 Q4 | 53.35 Million CNY | 0.0% |
| 2017 FY | 233.73 Million CNY | -5.8% |
| 2016 FY | 248.13 Million CNY | 58.07% |
| 2015 FY | 156.97 Million CNY | -20.89% |
| 2014 FY | 198.42 Million CNY | 0.0% |